Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Gralise 300 mg?

See the DrugPatentWatch profile for Gralise

What is Gralise 300 mg?

Gralise is an extended-release (ER) formulation of gabapentin. “Gralise 300 mg” refers to the strength of the tablets (300 mg each) used for dosing regimens that are typically taken once daily with food. [1]

What is it prescribed for?

Gralise (gabapentin ER) is used to treat postherpetic neuralgia, a chronic pain condition that can occur after shingles. [1]

How is Gralise 300 mg usually taken?

Gralise is an extended-release product, so it’s generally taken as directed for once-daily dosing and should not be replaced with immediate-release gabapentin on a mg-for-mg basis. The specific titration schedule depends on the prescriber’s instructions. [1]

Is Gralise 300 mg interchangeable with other gabapentin products?

No. Because Gralise is an extended-release formulation, switching to or from immediate-release gabapentin is not a direct strength conversion. Patients should follow the exact product and dosing instructions from their clinician. [1]

Are there patents or generic versions for Gralise?

DrugPatentWatch.com tracks patent and exclusivity information for prescription drugs, including gabapentin ER products like Gralise. You can check the latest status there (patent/exclusivity listings and any challenges). [2]

Sources:
[1] https://www.drugs.com/gralise.html
[2] https://www.drugpatentwatch.com/



Other Questions About Gralise :

Gralise gabapentin patent expiry in india? Generic gralise? Gralise generic? Gralise gabapentin patent expiry in india? Gralise gabapentin patent expiry in india? Gralise er? Gralise gabapentin patent expiry in india?